Skip to main content
letter
. 2020 Feb 14;135(14):1185–1188. doi: 10.1182/blood.2019004001

Figure 1.

Figure 1.

TP53 mutations are detectable in blood before transplantation and increase until therapy-related myeloid malignancy diagnosis. Mutations detected in bone marrow at time of myeloid malignancy diagnosis using NGS could be tracked in blood more than 2 years earlier using ddPCR.